Global Veterinary Vaccine Market Growth 2022-2028


Mar, 2022 | Report ID: 230958 | 165 | Medical Devices

As the global economy mends, the 2021 growth of Veterinary Vaccine will have significant change from previous year. According to our latest study, the global Veterinary Vaccine market size is USD million in 2022 from USD 8123.4 million in 2021, with a change of % between 2021 and 2022. The global Veterinary Vaccine market size will reach USD 12480 million in 2028, growing at a CAGR of 6.3% over the analysis period.

The United States Veterinary Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Veterinary Vaccine market, reaching US$ million by the year 2028. As for the Europe Veterinary Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Veterinary Vaccine players cover Merck, Zoetis, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live Attenuated Vaccines

Inactivated Vaccines

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Livestock

Swine

Chicken

Dog & Cat

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

BioTestLab

RVSRI

Medion


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Veterinary Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Veterinary Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Veterinary Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Veterinary Vaccine Segment by Type

2.2.1 Live Attenuated Vaccines

2.2.2 Inactivated Vaccines

2.2.3 Others

2.3 Veterinary Vaccine Sales by Type

2.3.1 Global Veterinary Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Veterinary Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Veterinary Vaccine Sale Price by Type (2017-2022)

2.4 Veterinary Vaccine Segment by Application

2.4.1 Livestock

2.4.2 Swine

2.4.3 Chicken

2.4.4 Dog & Cat

2.4.5 Others

2.5 Veterinary Vaccine Sales by Application

2.5.1 Global Veterinary Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Veterinary Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Veterinary Vaccine Sale Price by Application (2017-2022)

3 Global Veterinary Vaccine by Company

3.1 Global Veterinary Vaccine Breakdown Data by Company

3.1.1 Global Veterinary Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Veterinary Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Veterinary Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Veterinary Vaccine Revenue by Company (2020-2022)

3.2.2 Global Veterinary Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Veterinary Vaccine Sale Price by Company

3.4 Key Manufacturers Veterinary Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Veterinary Vaccine Product Location Distribution

3.4.2 Players Veterinary Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Veterinary Vaccine by Geographic Region

4.1 World Historic Veterinary Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Veterinary Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Veterinary Vaccine Annual Revenue by Geographic Region

4.2 World Historic Veterinary Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Veterinary Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Veterinary Vaccine Annual Revenue by Country/Region

4.3 Americas Veterinary Vaccine Sales Growth

4.4 APAC Veterinary Vaccine Sales Growth

4.5 Europe Veterinary Vaccine Sales Growth

4.6 Middle East & Africa Veterinary Vaccine Sales Growth

5 Americas

5.1 Americas Veterinary Vaccine Sales by Country

5.1.1 Americas Veterinary Vaccine Sales by Country (2017-2022)

5.1.2 Americas Veterinary Vaccine Revenue by Country (2017-2022)

5.2 Americas Veterinary Vaccine Sales by Type

5.3 Americas Veterinary Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Veterinary Vaccine Sales by Region

6.1.1 APAC Veterinary Vaccine Sales by Region (2017-2022)

6.1.2 APAC Veterinary Vaccine Revenue by Region (2017-2022)

6.2 APAC Veterinary Vaccine Sales by Type

6.3 APAC Veterinary Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Veterinary Vaccine by Country

7.1.1 Europe Veterinary Vaccine Sales by Country (2017-2022)

7.1.2 Europe Veterinary Vaccine Revenue by Country (2017-2022)

7.2 Europe Veterinary Vaccine Sales by Type

7.3 Europe Veterinary Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Veterinary Vaccine by Country

8.1.1 Middle East & Africa Veterinary Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Veterinary Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Veterinary Vaccine Sales by Type

8.3 Middle East & Africa Veterinary Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Veterinary Vaccine

10.3 Manufacturing Process Analysis of Veterinary Vaccine

10.4 Industry Chain Structure of Veterinary Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Veterinary Vaccine Distributors

11.3 Veterinary Vaccine Customer

12 World Forecast Review for Veterinary Vaccine by Geographic Region

12.1 Global Veterinary Vaccine Market Size Forecast by Region

12.1.1 Global Veterinary Vaccine Forecast by Region (2023-2028)

12.1.2 Global Veterinary Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Veterinary Vaccine Forecast by Type

12.7 Global Veterinary Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Veterinary Vaccine Product Offered

13.1.3 Merck Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Zoetis

13.2.1 Zoetis Company Information

13.2.2 Zoetis Veterinary Vaccine Product Offered

13.2.3 Zoetis Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Zoetis Main Business Overview

13.2.5 Zoetis Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Veterinary Vaccine Product Offered

13.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva

13.4.1 Ceva Company Information

13.4.2 Ceva Veterinary Vaccine Product Offered

13.4.3 Ceva Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Main Business Overview

13.4.5 Ceva Latest Developments

13.5 CAHIC

13.5.1 CAHIC Company Information

13.5.2 CAHIC Veterinary Vaccine Product Offered

13.5.3 CAHIC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CAHIC Main Business Overview

13.5.5 CAHIC Latest Developments

13.6 HVRI

13.6.1 HVRI Company Information

13.6.2 HVRI Veterinary Vaccine Product Offered

13.6.3 HVRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 HVRI Main Business Overview

13.6.5 HVRI Latest Developments

13.7 Ringpu Biology

13.7.1 Ringpu Biology Company Information

13.7.2 Ringpu Biology Veterinary Vaccine Product Offered

13.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ringpu Biology Main Business Overview

13.7.5 Ringpu Biology Latest Developments

13.8 Yebio

13.8.1 Yebio Company Information

13.8.2 Yebio Veterinary Vaccine Product Offered

13.8.3 Yebio Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Yebio Main Business Overview

13.8.5 Yebio Latest Developments

13.9 DHN

13.9.1 DHN Company Information

13.9.2 DHN Veterinary Vaccine Product Offered

13.9.3 DHN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 DHN Main Business Overview

13.9.5 DHN Latest Developments

13.10 WINSUN

13.10.1 WINSUN Company Information

13.10.2 WINSUN Veterinary Vaccine Product Offered

13.10.3 WINSUN Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 WINSUN Main Business Overview

13.10.5 WINSUN Latest Developments

13.11 Elanco

13.11.1 Elanco Company Information

13.11.2 Elanco Veterinary Vaccine Product Offered

13.11.3 Elanco Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Elanco Main Business Overview

13.11.5 Elanco Latest Developments

13.12 Virbac

13.12.1 Virbac Company Information

13.12.2 Virbac Veterinary Vaccine Product Offered

13.12.3 Virbac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Virbac Main Business Overview

13.12.5 Virbac Latest Developments

13.13 Jinyu Bio-Technology

13.13.1 Jinyu Bio-Technology Company Information

13.13.2 Jinyu Bio-Technology Veterinary Vaccine Product Offered

13.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Jinyu Bio-Technology Main Business Overview

13.13.5 Jinyu Bio-Technology Latest Developments

13.14 ChengDu Tecbond

13.14.1 ChengDu Tecbond Company Information

13.14.2 ChengDu Tecbond Veterinary Vaccine Product Offered

13.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 ChengDu Tecbond Main Business Overview

13.14.5 ChengDu Tecbond Latest Developments

13.15 CAVAC

13.15.1 CAVAC Company Information

13.15.2 CAVAC Veterinary Vaccine Product Offered

13.15.3 CAVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 CAVAC Main Business Overview

13.15.5 CAVAC Latest Developments

13.16 Kyoto Biken Laboratories

13.16.1 Kyoto Biken Laboratories Company Information

13.16.2 Kyoto Biken Laboratories Veterinary Vaccine Product Offered

13.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Kyoto Biken Laboratories Main Business Overview

13.16.5 Kyoto Biken Laboratories Latest Developments

13.17 FATRO

13.17.1 FATRO Company Information

13.17.2 FATRO Veterinary Vaccine Product Offered

13.17.3 FATRO Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 FATRO Main Business Overview

13.17.5 FATRO Latest Developments

13.18 Vaksindo

13.18.1 Vaksindo Company Information

13.18.2 Vaksindo Veterinary Vaccine Product Offered

13.18.3 Vaksindo Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Vaksindo Main Business Overview

13.18.5 Vaksindo Latest Developments

13.19 Bio-Labs

13.19.1 Bio-Labs Company Information

13.19.2 Bio-Labs Veterinary Vaccine Product Offered

13.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Bio-Labs Main Business Overview

13.19.5 Bio-Labs Latest Developments

13.20 Avimex Animal Health

13.20.1 Avimex Animal Health Company Information

13.20.2 Avimex Animal Health Veterinary Vaccine Product Offered

13.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Avimex Animal Health Main Business Overview

13.20.5 Avimex Animal Health Latest Developments

13.21 MEVAC

13.21.1 MEVAC Company Information

13.21.2 MEVAC Veterinary Vaccine Product Offered

13.21.3 MEVAC Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 MEVAC Main Business Overview

13.21.5 MEVAC Latest Developments

13.22 Biovac

13.22.1 Biovac Company Information

13.22.2 Biovac Veterinary Vaccine Product Offered

13.22.3 Biovac Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Biovac Main Business Overview

13.22.5 Biovac Latest Developments

13.23 Atafen

13.23.1 Atafen Company Information

13.23.2 Atafen Veterinary Vaccine Product Offered

13.23.3 Atafen Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Atafen Main Business Overview

13.23.5 Atafen Latest Developments

13.24 Dyntec

13.24.1 Dyntec Company Information

13.24.2 Dyntec Veterinary Vaccine Product Offered

13.24.3 Dyntec Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Dyntec Main Business Overview

13.24.5 Dyntec Latest Developments

13.25 BioTestLab

13.25.1 BioTestLab Company Information

13.25.2 BioTestLab Veterinary Vaccine Product Offered

13.25.3 BioTestLab Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 BioTestLab Main Business Overview

13.25.5 BioTestLab Latest Developments

13.26 RVSRI

13.26.1 RVSRI Company Information

13.26.2 RVSRI Veterinary Vaccine Product Offered

13.26.3 RVSRI Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 RVSRI Main Business Overview

13.26.5 RVSRI Latest Developments

13.27 Medion

13.27.1 Medion Company Information

13.27.2 Medion Veterinary Vaccine Product Offered

13.27.3 Medion Veterinary Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Medion Main Business Overview

13.27.5 Medion Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Veterinary Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Veterinary Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Attenuated Vaccines

Table 4. Major Players of Inactivated Vaccines

Table 5. Major Players of Others

Table 6. Global Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)

Table 7. Global Veterinary Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global Veterinary Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Veterinary Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global Veterinary Vaccine Sale Price by Type (2017-2022) & (USD/Doses)

Table 11. Global Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)

Table 12. Global Veterinary Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global Veterinary Vaccine Revenue by Application (2017-2022)

Table 14. Global Veterinary Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global Veterinary Vaccine Sale Price by Application (2017-2022) & (USD/Doses)

Table 16. Global Veterinary Vaccine Sales by Company (2020-2022) & (M Doses)

Table 17. Global Veterinary Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global Veterinary Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Veterinary Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global Veterinary Vaccine Sale Price by Company (2020-2022) & (USD/Doses)

Table 21. Key Manufacturers Veterinary Vaccine Producing Area Distribution and Sales Area

Table 22. Players Veterinary Vaccine Products Offered

Table 23. Veterinary Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Veterinary Vaccine Sales by Geographic Region (2017-2022) & (M Doses)

Table 27. Global Veterinary Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Veterinary Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Veterinary Vaccine Sales by Country/Region (2017-2022) & (M Doses)

Table 31. Global Veterinary Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Veterinary Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Veterinary Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)

Table 35. Americas Veterinary Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas Veterinary Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Veterinary Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)

Table 39. Americas Veterinary Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)

Table 41. Americas Veterinary Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC Veterinary Vaccine Sales by Region (2017-2022) & (M Doses)

Table 43. APAC Veterinary Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC Veterinary Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Veterinary Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)

Table 47. APAC Veterinary Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)

Table 49. APAC Veterinary Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)

Table 51. Europe Veterinary Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe Veterinary Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Veterinary Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)

Table 55. Europe Veterinary Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)

Table 57. Europe Veterinary Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Veterinary Vaccine Sales by Country (2017-2022) & (M Doses)

Table 59. Middle East & Africa Veterinary Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Veterinary Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Veterinary Vaccine Sales by Type (2017-2022) & (M Doses)

Table 63. Middle East & Africa Veterinary Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Veterinary Vaccine Sales by Application (2017-2022) & (M Doses)

Table 65. Middle East & Africa Veterinary Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Veterinary Vaccine

Table 67. Key Market Challenges & Risks of Veterinary Vaccine

Table 68. Key Industry Trends of Veterinary Vaccine

Table 69. Veterinary Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Veterinary Vaccine Distributors List

Table 72. Veterinary Vaccine Customer List

Table 73. Global Veterinary Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 74. Global Veterinary Vaccine Sales Market Forecast by Region

Table 75. Global Veterinary Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Veterinary Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 78. Americas Veterinary Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Veterinary Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 80. APAC Veterinary Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Veterinary Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 82. Europe Veterinary Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Veterinary Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 84. Middle East & Africa Veterinary Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Veterinary Vaccine Sales Forecast by Type (2023-2028) & (M Doses)

Table 86. Global Veterinary Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Veterinary Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Veterinary Vaccine Sales Forecast by Application (2023-2028) & (M Doses)

Table 90. Global Veterinary Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Veterinary Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck Veterinary Vaccine Product Offered

Table 95. Merck Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Zoetis Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Zoetis Veterinary Vaccine Product Offered

Table 100. Zoetis Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 101. Zoetis Main Business

Table 102. Zoetis Latest Developments

Table 103. Boehringer Ingelheim Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Boehringer Ingelheim Veterinary Vaccine Product Offered

Table 105. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 106. Boehringer Ingelheim Main Business

Table 107. Boehringer Ingelheim Latest Developments

Table 108. Ceva Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. Ceva Veterinary Vaccine Product Offered

Table 110. Ceva Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 111. Ceva Main Business

Table 112. Ceva Latest Developments

Table 113. CAHIC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. CAHIC Veterinary Vaccine Product Offered

Table 115. CAHIC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 116. CAHIC Main Business

Table 117. CAHIC Latest Developments

Table 118. HVRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 119. HVRI Veterinary Vaccine Product Offered

Table 120. HVRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 121. HVRI Main Business

Table 122. HVRI Latest Developments

Table 123. Ringpu Biology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 124. Ringpu Biology Veterinary Vaccine Product Offered

Table 125. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 126. Ringpu Biology Main Business

Table 127. Ringpu Biology Latest Developments

Table 128. Yebio Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 129. Yebio Veterinary Vaccine Product Offered

Table 130. Yebio Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 131. Yebio Main Business

Table 132. Yebio Latest Developments

Table 133. DHN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 134. DHN Veterinary Vaccine Product Offered

Table 135. DHN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 136. DHN Main Business

Table 137. DHN Latest Developments

Table 138. WINSUN Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 139. WINSUN Veterinary Vaccine Product Offered

Table 140. WINSUN Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 141. WINSUN Main Business

Table 142. WINSUN Latest Developments

Table 143. Elanco Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 144. Elanco Veterinary Vaccine Product Offered

Table 145. Elanco Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 146. Elanco Main Business

Table 147. Elanco Latest Developments

Table 148. Virbac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 149. Virbac Veterinary Vaccine Product Offered

Table 150. Virbac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 151. Virbac Main Business

Table 152. Virbac Latest Developments

Table 153. Jinyu Bio-Technology Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 154. Jinyu Bio-Technology Veterinary Vaccine Product Offered

Table 155. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 156. Jinyu Bio-Technology Main Business

Table 157. Jinyu Bio-Technology Latest Developments

Table 158. ChengDu Tecbond Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 159. ChengDu Tecbond Veterinary Vaccine Product Offered

Table 160. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 161. ChengDu Tecbond Main Business

Table 162. ChengDu Tecbond Latest Developments

Table 163. CAVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 164. CAVAC Veterinary Vaccine Product Offered

Table 165. CAVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 166. CAVAC Main Business

Table 167. CAVAC Latest Developments

Table 168. Kyoto Biken Laboratories Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 169. Kyoto Biken Laboratories Veterinary Vaccine Product Offered

Table 170. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 171. Kyoto Biken Laboratories Main Business

Table 172. Kyoto Biken Laboratories Latest Developments

Table 173. FATRO Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 174. FATRO Veterinary Vaccine Product Offered

Table 175. FATRO Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 176. FATRO Main Business

Table 177. FATRO Latest Developments

Table 178. Vaksindo Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 179. Vaksindo Veterinary Vaccine Product Offered

Table 180. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 181. Vaksindo Main Business

Table 182. Vaksindo Latest Developments

Table 183. Bio-Labs Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 184. Bio-Labs Veterinary Vaccine Product Offered

Table 185. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 186. Bio-Labs Main Business

Table 187. Bio-Labs Latest Developments

Table 188. Avimex Animal Health Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 189. Avimex Animal Health Veterinary Vaccine Product Offered

Table 190. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 191. Avimex Animal Health Main Business

Table 192. Avimex Animal Health Latest Developments

Table 193. MEVAC Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 194. MEVAC Veterinary Vaccine Product Offered

Table 195. MEVAC Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 196. MEVAC Main Business

Table 197. MEVAC Latest Developments

Table 198. Biovac Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 199. Biovac Veterinary Vaccine Product Offered

Table 200. Biovac Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 201. Biovac Main Business

Table 202. Biovac Latest Developments

Table 203. Atafen Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 204. Atafen Veterinary Vaccine Product Offered

Table 205. Atafen Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 206. Atafen Main Business

Table 207. Atafen Latest Developments

Table 208. Dyntec Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 209. Dyntec Veterinary Vaccine Product Offered

Table 210. Dyntec Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 211. Dyntec Main Business

Table 212. Dyntec Latest Developments

Table 213. BioTestLab Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 214. BioTestLab Veterinary Vaccine Product Offered

Table 215. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 216. BioTestLab Main Business

Table 217. BioTestLab Latest Developments

Table 218. RVSRI Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 219. RVSRI Veterinary Vaccine Product Offered

Table 220. RVSRI Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 221. RVSRI Main Business

Table 222. RVSRI Latest Developments

Table 223. Medion Basic Information, Veterinary Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 224. Medion Veterinary Vaccine Product Offered

Table 225. Medion Veterinary Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 226. Medion Main Business

Table 227. Medion Latest Developments

List of Figures

Figure 1. Picture of Veterinary Vaccine

Figure 2. Veterinary Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Veterinary Vaccine Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Veterinary Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Veterinary Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Attenuated Vaccines

Figure 10. Product Picture of Inactivated Vaccines

Figure 11. Product Picture of Others

Figure 12. Global Veterinary Vaccine Sales Market Share by Type in 2021

Figure 13. Global Veterinary Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. Veterinary Vaccine Consumed in Livestock

Figure 15. Global Veterinary Vaccine Market: Livestock (2017-2022) & (M Doses)

Figure 16. Veterinary Vaccine Consumed in Swine

Figure 17. Global Veterinary Vaccine Market: Swine (2017-2022) & (M Doses)

Figure 18. Veterinary Vaccine Consumed in Chicken

Figure 19. Global Veterinary Vaccine Market: Chicken (2017-2022) & (M Doses)

Figure 20. Veterinary Vaccine Consumed in Dog & Cat

Figure 21. Global Veterinary Vaccine Market: Dog & Cat (2017-2022) & (M Doses)

Figure 22. Veterinary Vaccine Consumed in Others

Figure 23. Global Veterinary Vaccine Market: Others (2017-2022) & (M Doses)

Figure 24. Global Veterinary Vaccine Sales Market Share by Application (2017-2022)

Figure 25. Global Veterinary Vaccine Revenue Market Share by Application in 2021

Figure 26. Veterinary Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Veterinary Vaccine Revenue Market Share by Company in 2021

Figure 28. Global Veterinary Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Veterinary Vaccine Revenue Market Share by Geographic Region in 2021

Figure 30. Global Veterinary Vaccine Sales Market Share by Region (2017-2022)

Figure 31. Global Veterinary Vaccine Revenue Market Share by Country/Region in 2021

Figure 32. Americas Veterinary Vaccine Sales 2017-2022 (M Doses)

Figure 33. Americas Veterinary Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. APAC Veterinary Vaccine Sales 2017-2022 (M Doses)

Figure 35. APAC Veterinary Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Europe Veterinary Vaccine Sales 2017-2022 (M Doses)

Figure 37. Europe Veterinary Vaccine Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Veterinary Vaccine Sales 2017-2022 (M Doses)

Figure 39. Middle East & Africa Veterinary Vaccine Revenue 2017-2022 ($ Millions)

Figure 40. Americas Veterinary Vaccine Sales Market Share by Country in 2021

Figure 41. Americas Veterinary Vaccine Revenue Market Share by Country in 2021

Figure 42. United States Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Veterinary Vaccine Sales Market Share by Region in 2021

Figure 47. APAC Veterinary Vaccine Revenue Market Share by Regions in 2021

Figure 48. China Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Veterinary Vaccine Sales Market Share by Country in 2021

Figure 55. Europe Veterinary Vaccine Revenue Market Share by Country in 2021

Figure 56. Germany Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Veterinary Vaccine Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Veterinary Vaccine Revenue Market Share by Country in 2021

Figure 63. Egypt Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Veterinary Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Veterinary Vaccine in 2021

Figure 69. Manufacturing Process Analysis of Veterinary Vaccine

Figure 70. Industry Chain Structure of Veterinary Vaccine

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

Sample Request is not available